Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$887M |
| 2 |
Amazon
AMZN
|
+$857M |
| 3 |
Apple
AAPL
|
+$844M |
| 4 |
Microsoft
MSFT
|
+$802M |
| 5 |
Tesla
TSLA
|
+$606M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$760M |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$515M |
| 3 |
WORK
Slack Technologies, Inc.
WORK
|
+$258M |
| 4 |
Oracle
ORCL
|
+$126M |
| 5 |
PFPT
Proofpoint, Inc.
PFPT
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.53% |
| 2 | Financials | 13.97% |
| 3 | Healthcare | 13.42% |
| 4 | Consumer Discretionary | 11.85% |
| 5 | Communication Services | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1701
Revolution Medicines
RVMD
$43.6B
| $29.7M | ﹤0.01% |
1,080,939
+136,881
| +14% | +$3.98M |
|
1702
Provident Financial Services
PFS
$3.26B
| $29.6M | ﹤0.01% |
1,259,170
+19,491
| +2% | +$430K |
|
1703
Infosys
INFY
$49.5B
| $29.5M | ﹤0.01% |
1,327,178
+8,280
| +0.6% | +$187K |
|
1704
Enterprise Financial Services Corp
EFSC
$2.42B
| $29.3M | ﹤0.01% |
646,943
+126,000
| +24% | +$5.65M |
|
|
VNE
1705
DELISTED
Veoneer, Inc.
VNE
| $29.3M | ﹤0.01% |
859,868
+33,580
| +4% | +$1.07M |
|
|
VGR
1706
DELISTED
Vector Group Ltd.
VGR
| $29.3M | ﹤0.01% |
3,236,405
-34,204
| -1% | -$334K |
|
|
ARGO
1707
DELISTED
Argo Group International Holdings, Ltd.
ARGO
| $29.1M | ﹤0.01% |
557,536
+18,379
| +3% | +$966K |
|
|
ADAM
1708
Adamas Trust
ADAM
$918M
| $29.1M | ﹤0.01% |
1,706,091
+25,995
| +2% | +$452K |
|
1709
Brookfield Renewable
BEPC
$6.61B
| $29M | ﹤0.01% |
749,225
+56,173
| +8% | +$2.35M |
|
|
HMHC
1710
DELISTED
Houghton Mifflin Harcourt Company
HMHC
| $28.9M | ﹤0.01% |
2,150,694
+11,661
| +0.5% | +$147K |
|
1711
Ameresco
AMRC
$1.48B
| $28.9M | ﹤0.01% |
494,234
+57,372
| +13% | +$3.78M |
|
1712
iRhythm Holdings
IRTC
$4.11B
| $28.8M | ﹤0.01% |
492,004
-9,535
| -2% | -$505K |
|
1713
Eagle Bancorp
EGBN
$880M
| $28.8M | ﹤0.01% |
500,095
-49,977
| -9% | -$2.8M |
|
1714
Empire State Realty Trust
ESRT
$838M
| $28.6M | ﹤0.01% |
2,848,735
+53,864
| +2% | +$581K |
|
1715
Laureate Education
LAUR
$5.17B
| $28.6M | ﹤0.01% |
1,680,873
-169,261
| -9% | -$2.66M |
|
1716
Knowles
KN
$3.3B
| $28.5M | ﹤0.01% |
1,523,264
+15,873
| +1% | +$310K |
|
1717
Stewart Information Services
STC
$2.03B
| $28.5M | ﹤0.01% |
450,998
+70
| +0% | +$4.17K |
|
1718
Cimpress
CMPR
$2.35B
| $28.5M | ﹤0.01% |
327,810
+5,727
| +2% | +$562K |
|
1719
Teck Resources
TECK
$31.3B
| $28.2M | ﹤0.01% |
1,142,620
+136,777
| +14% | +$3.13M |
|
1720
Opko Health
OPK
$1.04B
| $28.2M | ﹤0.01% |
7,728,730
-53,188
| -0.7% | -$198K |
|
|
JAMF
1721
DELISTED
Jamf
JAMF
| $28.2M | ﹤0.01% |
731,352
+173,934
| +31% | +$5.97M |
|
1722
Quanterix
QTRX
$139M
| $28.1M | ﹤0.01% |
565,274
+47,563
| +9% | +$2.45M |
|
1723
Super Micro Computer
SMCI
$26B
| $28.1M | ﹤0.01% |
7,688,680
-20,830
| -0.3% | -$75.6K |
|
1724
TechnipFMC
FTI
$29.9B
| $28M | ﹤0.01% |
3,719,135
+27,419
| +0.7% | +$197K |
|
1725
Stride
LRN
$3.41B
| $28M | ﹤0.01% |
778,702
+56,774
| +8% | +$1.86M |
|
Similar funds
Geode Capital Management's Q3 2021 Portfolio in Review
As of Q3 2021, Geode Capital Management held 4,944 positions worth $743B, up 2.3% from $726B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Geode Capital Management's Q3 2021 filing shows 223 new, 2,961 increased, 1,210 reduced and 86 closed positions. Its largest new stake was Lucid Motors: 565,353 shares worth $143M. The largest sale was Alexion Pharmaceuticals, an estimated $760M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q3 2021 buy was Lucid Motors: 565,353 shares worth $143M.
- Geode Capital Management added most to Moderna in Q3 2021, an estimated $887M increase.
- Geode Capital Management's biggest Q3 2021 reduction was Oracle, cutting an estimated $126M.
- Geode Capital Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $760M.
- Geode Capital Management's ten largest holdings make up 23% of its $743B portfolio in Q3 2021.
- Geode Capital Management opened 223 new positions and closed 86 in Q3 2021.
- Geode Capital Management's portfolio value rose 2.3% quarter-over-quarter to $743B.
Based on Geode Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.